(Q40164349)

18 September 2017

Delta 9-tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells (English)

1 reference

18 September 2017

1 reference

0 references

1 reference

1 reference

6

Raphael Mechoulam

1 reference

18 September 2017

9

Gideon Rechavi

1 reference

18 September 2017

8

Ninette Amariglio

1 reference

18 September 2017

2

Tamar Fisher

1 reference

18 September 2017

1

Gil Galanti

1 reference

18 September 2017

7

Gad Lavie

1 reference

18 September 2017

3

Iris Kventsel

1 reference

18 September 2017

10

Amos Toren

1 reference

18 September 2017

5

Ruth Gallily

1 reference

18 September 2017

Jacob Shoham

4

1 reference

18 September 2017

1 January 2008

1 reference

PubMed ID

17934890

full work available at URL

18 September 2017

https://www.tandfonline.com/doi/pdf/10.1080/02841860701678787?needAccess=true

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1080/02841860701678787?email=unpaywall_01@example.com

published in

Acta Oncologica

1 reference

18 September 2017

47

1 reference

18 September 2017

6

1 reference

18 September 2017

1062-1070

1 reference

https://api.unpaywall.org/v2/10.1080/02841860701678787?email=unpaywall_01@example.com

18 September 2017

1 reference

19 March 2024

access restriction status

open access

1 reference

based on heuristic

inferred from online access status

cites work

Chemotherapeutic dose intensification for treatment of malignant brain tumors: recent developments and future directions

1 reference

https://api.crossref.org/works/10.1080%2F02841860701678787

PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701678787

The endocannabinoid nervous system: unique opportunities for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701678787

Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701678787

Control of the cell survival/death decision by cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701678787

Delta9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701678787

Principles of CDK regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701678787

Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701678787

The regulation of E2F by pRB-family proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701678787

Clinical significance of thymidylate synthase expression in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701678787

Adenovirus-mediated p16/CDKN2 gene transfer suppresses glioma invasion in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701678787

Ubiquitin-mediated proteolysis of vertebrate G1- and S-phase regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701678787

Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701678787

10.1080/02841860701678787

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference

PubMed ID

17934890